Get a clear overview of all current promotions and deals from our suppliers.
Can’t find a product in our catalog, or need a fully custom solution? We’ve got you covered.
Looking for specific products, alternatives, documentation or any other assistance? We’re here to help.
Connect with us in person, and let us connect you to the right products and suppliers for your research.
With the “Local & Sustainable Sourcing” theme, Bio-Connect connects Benelux researchers to European and Dutch suppliers of animal free, recombinant and sustainable solutions through one local sourcing partner in the heart of Europe.
PromoCell is a biotechnology company with over 35 years of experience in human cell culture. The company supports researchers worldwide with xeno free, serum free media, enabling modern animal free cell culture, backed by short, reliable European supply chains.
DIAsource ImmunoAssays delivers an extensive portfolio of ELISA and RIA kits from Belgium to Benelux laboratories, with a strong focus on endocrinology, infectious diseases and traceable IVD quality.
Cell4Pharma brings advanced vesicular transport and nephrotoxicity assays to Benelux researchers, enabling local in vitro DDI studies and helping to reduce animal use and global supply risks.
Basic Pharma offers recombinant human serum albumin (rHSA) produced locally in the Netherlands, providing Benelux researchers a reliable, animal free alternative to plasma-derived albumin.
Sino Biological ProPure™ endotoxin-free proteins minimize LPS contamination, safeguard biopharmaceutical research accuracy, and support safer drug development.
Check out Bio-Connect‘s May 2026 Highlights: Promotions, News and Innovations, New Partnerships and Upcoming Events.
BPS Bioscience’s commercial kits save time by providing consistent, pre-optimized reagents and protocols, enabling reliable results and making advanced experimental workflows accessible to researchers without specialized expertise.
Prolytix pooled platelet poor plasma (HPPP-0400) delivers consistency, low platelet counts, and verified coagulation performance for coagulation testing and assay development and validation.
In immune cell culture, high-quality cytokines from MedChem Express unlock the potential of cells, guiding their fate with precision and enabling more efficient, reliable experimental outcomes.
Assay Genie‘s Bioprocess Kits deliver reliable tools for monitoring Host Cell Proteins, residual DNA, vector quantification, and viral titers, supporting every stage of biopharmaceutical development.
Bio X Cell RecombiMAb in vivo recombinant antibodies are engineered to give researchers deliberate control over antibody biology so that data reflects the mechanism, not the molecule.
As stem cell research moves toward clinical use, PromoCell supports the need for scalable, reproducible, and regulatory-aligned cell culture systems in regenerative medicine.
BLD Pharm provides high-quality peptide molecules for scientific research, giving scientists and laboratories reliable materials to drive innovative discoveries.
BLD Pharm offers a comprehensive portfolio of targeted protein degraders, including PROTACs, molecular glues, and building blocks (linkers & E3 ligase ligands), for chemical biology and oncology research.
How can cartilage breakdown be tracked and do why sample type matter? Human Cartialge Oligomeric Matrix Protein ELISA from BioVendor offers answers to these questions.
Provis Biolabs offers Provinase®, a GMP-grade recombinant endonuclease engineered for efficient residual DNA removal in AAV, lentiviral and cell therapy manufacturing workflows.
INDIGO Biosciences supports metabolic disease research beyond GLP-1R with cell-based assays targeting complementary pathways involved in metabolic regulation.
Vector Laboratories‘ Glysite™ Explorer in situ PLA Glycan Detection Kit is now available through Bio-Connect. This first-of-its-kind tool transforms the way researchers approach spatial glycosylation.
The new Bio-Connect website is live, designed to help you find products, services and scientific content faster so you can focus on advancing your research.
DNA damage threatens genome integrity, aging, and cancer biology. Learn why this field matters and how Bioss supports DNA damage research with antibodies to key DDR biomarkers.
In this article, MedChem Express reviews the evolution and pipeline of personalized cancer vaccines, highlighting neoantigen sources, screening technologies, and key translational challenges.
OriGene Technologies launches a fast, ultracentrifuge-free EV Isolation Reagent and a new Exosome ELISA Kit (CD9), delivering high-yield EV recovery and sensitive quantification for exosome research.
Solis BioDyne’s SolisAcura™ polymerase supports allele-specific PCR assays used for SNP genotyping in agriculture. Learn how optimized enzymes improve accuracy and throughput in crop genetics.
Medicina expands its gastrostomy portfolio with the GFit Button and GFit Tube, providing practical, patient‑focused solutions for safe, long‑term enteral feeding.
AtlasPlex by Atlas Antibodies simplifies tissue mapping multiplex immunohistochemistry in FFPE samples with a flexible, ready-to-use mIHC assay, delivering up to 5 plex in a single day with unmatched clarity.
Discover the latest edition of Svar’s Complement System Specialist Review, offering expert insights into complement biology, disease mechanisms, and emerging therapeutic opportunities.
CUSABIO’s research-grade biosimilar antibodies offer 100% sequence identity to approved drugs. Low-endotoxin and azide-free, they are ideal for PK assays, functional validation, and preclinical studies
With complete biological definition and ensured reproducibility, recombinant antibodies from Absolute Antibody, a Vector Laboratories company, power researchers to study areas like neuroscience, infectious disease, and immunotherapy with confidence.
BioVendor’s innovative ELISA and POCT solutions reduce diagnostic uncertainty in bacterial and viral infections, with MxA setting a new standard for diagnostic innovation.
We gladly support you by keeping you updated on our latest products and developments